The advantage of specific intravenous immunoglobulin (sIVIG) on regular IVIG: experience of the last decade.
about
Intravenous immunoglobulin and Alzheimer's disease: what now?Association of autoantibody specificity and response to intravenous immunoglobulin G therapy in immune thrombocytopenia: a multicenter cohort study.Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity.IVIG regulates the survival of human but not mouse neutrophils.Intravenous immunoglobulin-mediated immunosuppression and the development of an IVIG substitute.Mechanisms and potential therapeutic targets in allergic inflammation: recent insights.Should development of Alzheimer's disease-specific intravenous immunoglobulin be considered?Intravenous Immunoglobulin and Immunomodulation of B-Cell - in vitro and in vivo Effects.Clinical Use and Therapeutic Potential of IVIG/SCIG, Plasma-Derived IgA or IgM, and Other Alternative Immunoglobulin Preparations.10% liquid human immunoglobulin (KIOVIG(®)) for immunomodulation in autoimmune disorders.Defective functions of polymorphonuclear neutrophils in patients with common variable immunodeficiency.Anti-citrullinated-protein-antibody-specific intravenous immunoglobulin attenuates collagen-induced arthritis in mice.Isolation of Antibodies from Human Plasma, Saliva, Breast Milk, and Gastrointestinal Fluid.Intravenous immunoglobulin exerts reciprocal regulation of Th1/Th17 cells and regulatory T cells in Guillain–Barré syndrome patientsIVIG pluripotency and the concept of Fc-sialylation: challenges to the scientist
P2860
Q27000371-46D20B11-FEE7-4D13-97AA-1D4E3DE96E59Q33413287-3F1D1108-7E19-42F8-A67B-C76D81577C93Q33420853-06A21F78-4574-4CF5-98EF-9098EA8B7847Q33683531-94E0322E-92AE-4F26-945B-6C55AEA61AC3Q38133405-8593A960-FEF4-40E3-A92D-512AA61D5D62Q38161574-947BC0BD-F60A-4B52-BB8A-75A769662030Q38283308-32B42707-D3AD-433B-B84C-008AF7EE454AQ38346284-9845264F-99FF-4DBA-938A-92343F8AF146Q38820288-DF8C01BF-3E23-4F5F-9538-5D73973E228AQ38820352-CC2E765C-9AE7-461F-AEB0-2C4E57690BAFQ46872401-B52B4462-E772-453C-9D6C-3CFD298C263DQ53445087-E0B37BB0-7516-4CDD-A7F3-8A413E6CA5C1Q53726982-4198833A-B736-48B5-9990-18C92E663D44Q58861212-07C25206-ECBB-42FA-892D-BD5D42FA1D00Q58861220-74CCE1BF-7353-4420-92D0-3A2BCCC7E0BD
P2860
The advantage of specific intravenous immunoglobulin (sIVIG) on regular IVIG: experience of the last decade.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The advantage of specific intr ...... experience of the last decade.
@en
type
label
The advantage of specific intr ...... experience of the last decade.
@en
prefLabel
The advantage of specific intr ...... experience of the last decade.
@en
P2093
P2860
P1476
The advantage of specific intr ...... experience of the last decade.
@en
P2093
Arie Altman
Hans-Jurgen Thiesen
Loic Guillevin
Luc Mouthon
Martine Szyper Kravitz
Nina Svetlicky
Oscar-Danilo Ortega-Hernandez
P2860
P2888
P304
P356
10.1007/S10875-012-9842-5
P478
33 Suppl 1
P577
2012-12-11T00:00:00Z
P6179
1001113146